1 reported on the development of anemia in the Leiden 85-Plus Study. Folate deficiency and elevated serum homocysteine level were associated with anemia both at baseline and at the 5-year follow-up.
Results. Of the 3015 subjects at BMES-2, 503 subjects who used any form of vitamin B 12 and/or folic acid supplements were excluded, leaving 2512 subjects. Elevated serum homocysteine level and vitamin B 12 deficiency were both associated with anemia (Table) . Both serum and red blood cell folate deficiency and dietary folate less than the recommended daily intake were not associated with anemia but were associated with elevated mean corpuscular volume.
In an adjusted logistic regression model including elevated homocysteine level and serum folate and vitamin B 12 deficiency, we observed an independent association between homocysteine and anemia (odds ratio, 3.78; 95% confidence interval, 2.12-6.74). At BMES-3, 21 subjects (7.0%) with elevated homocysteine levels had incident anemia (odds ratio, 2.09; 95% confidence interval, 1.01-4.30). Five-year incidence of anemia was not predicted by vitamin B 12 or serum folate deficiencies.
Comment. Our study confirms the findings by den Elzen et al 1 that elevated serum homocysteine level is associated with both prevalent and incident anemia, demonstrating that the Leiden 85-Plus Study findings extend down to persons 50 years and older. However, in contrast, we found that vitamin B 12 deficiency rather than serum folate deficiency was associated with prevalent anemia. This is a valid finding because anemia is one of the most frequent consequences of vitamin B 12 deficiency, and in developed countries, anemia due to folate deficiency is uncommon. 5, 6 Elevated mean corpuscular volume could be considered as a preanemia stage, which our study shows is associated with all the deficiencies we examined.
We provide evidence supporting screening and treatment of vitamin B 12 deficiency, which may attenuate the occurrence of anemia in older adults. This contrasts with the recommendations by den Elzen et al 1 for those 85 years and older. These conflicting results are not surprising, since a notable proportion of older anemic patients (30%-50%) are presumed to have multiple causes for their anemia. 2 Hence, both the Blue Mountains and Leiden 85-Plus studies demonstrate that successful treatment of nutrient-deficiency anemia depends on focusing particular attention to discerning underlying causes. 1 on their study, which found that simply giving smoking cessation counseling in the hospital, as mandated by current quality-initiative measures, does not result in smoking cessation. Factors that improved smoking cessation rates included receiving a referral to cardiac rehabilitation, the presence of a hospital-based smoking cessation program, and not experiencing depression. These findings are critical in helping to shape policy decisions regarding inpatient efforts to promote smoking cessation.
However, we are concerned with the authors' conclusion that "socioeconomic status of the patients did not predict" smoking cessation. 1(p1965) This finding is based on multivariable analyses that included "economic burden" as a potential predictor (defined as "reported avoiding health care owing to cost over the past year"
). There is some question as to the rationale and appropriateness of this single-item measure to capture the socioeconomic status construct. While economic burden may be a proxy for low socioeconomic status, it may not be specific to low-income patients and may include patients who were not financially disadvantaged but believed that health care expenses are not a priority. Moreover, it was unclear why the multivariable analyses did not include annual income less than $10 000 (which was a significant predictor of smoking cessation in the bivariate analyses).
The authors also suggest that smoking cessation programs be placed in hospitals caring for underprivileged and indigent populations to address socioeconomic inequities. However, we wish to highlight that the 
